Paul Tudor Jones II's position in Chemed is currently worth $2.78M. That's 0.02% of their equity portfolio (766th largest holding). The first Chemed trade was made in Q2 2013. Since then Paul Tudor Jones II bought shares eleven more times and sold shares on twelve occasions. The investor's estimated purchase price is $3.45M, resulting in a loss of 19%.